Lionel Calviere1,2, Nicolas Raposo3,4, Victor Cuvinciuc5, Christophe Cognard5, Fabrice Bonneville5,4, Alain Viguier3,4. 1. Department of Neurology, Hopital Pierre Paul Riquet, CHU Toulouse, Place Dr Baylac, 30159, Toulouse, France. calviere.l@chu-toulouse.fr. 2. Toulouse Neuroimaging Center, INSERM, UPS, Toulouse, France. calviere.l@chu-toulouse.fr. 3. Department of Neurology, Hopital Pierre Paul Riquet, CHU Toulouse, Place Dr Baylac, 30159, Toulouse, France. 4. Toulouse Neuroimaging Center, INSERM, UPS, Toulouse, France. 5. Department of Neuroradiology, Toulouse University Hospital, Toulouse, France.
Abstract
BACKGROUND: Cerebral amyloid angiopathy (CAA) is a common aetiology of convexal subarachnoid haemorrhage (cSAH) but little is known about its specific characteristics in comparison with cSAH from other causes. In this study we compared patients with CAA vs. non-CAA-related cSAH. METHODS: Retrospective review of baseline and follow-up data of consecutive patients admitted with a symptomatic acute cSAH. RESULTS: Sixty-two patients were included (mean age 66.2 ± 14.1 years), of whom 31 with probable CAA. CAA patients presented more frequently with transient symptoms (83.9 vs. 19.3%; p < 0.001) usually without headache (19.0 vs. 58.1%; p = 0.002). In CAA, these were essentially positive sensory disturbance that met the criteria of transient focal neurological episodes (TFNE). CAA was more often associated with cortical superficial siderosis (cSS) (80.6 vs. 0%; p < 0.001) and lobar cerebral microbleeds (83.4 vs. 9%; p < 0.001). During a mean of 22 months of follow-up, recurrent symptomatic cSAH occurred in 4/27 (12.9%) CAA patients and in 0/27 non-CAA patients. Among 40 patients with MRI follow-up, cSAH recurrences were observed in 44% of CAA patients vs. 13.3% of other cases (p = 0.08) and extension of cSS was detected only in CAA (60%) (p < 0.001). Acute cSAH evolved to cSS in 96 and 73.3% of CAA and non-CAA patients, respectively (p = 0.06). CONCLUSIONS: CAA differs from other cSAH in having TFNE as a frequent clinical presentation, a high prevalence of cSS and an increased risk of recurrent subarachnoid bleeding. However, evolution from acute cSAH to focal cSS may not be specific to CAA.
BACKGROUND:Cerebral amyloid angiopathy (CAA) is a common aetiology of convexal subarachnoid haemorrhage (cSAH) but little is known about its specific characteristics in comparison with cSAH from other causes. In this study we compared patients with CAA vs. non-CAA-related cSAH. METHODS: Retrospective review of baseline and follow-up data of consecutive patients admitted with a symptomatic acute cSAH. RESULTS: Sixty-two patients were included (mean age 66.2 ± 14.1 years), of whom 31 with probable CAA. CAA patients presented more frequently with transient symptoms (83.9 vs. 19.3%; p < 0.001) usually without headache (19.0 vs. 58.1%; p = 0.002). In CAA, these were essentially positive sensory disturbance that met the criteria of transient focal neurological episodes (TFNE). CAA was more often associated with cortical superficial siderosis (cSS) (80.6 vs. 0%; p < 0.001) and lobar cerebral microbleeds (83.4 vs. 9%; p < 0.001). During a mean of 22 months of follow-up, recurrent symptomatic cSAH occurred in 4/27 (12.9%) CAA patients and in 0/27 non-CAA patients. Among 40 patients with MRI follow-up, cSAH recurrences were observed in 44% of CAA patients vs. 13.3% of other cases (p = 0.08) and extension of cSS was detected only in CAA (60%) (p < 0.001). Acute cSAH evolved to cSS in 96 and 73.3% of CAA and non-CAA patients, respectively (p = 0.06). CONCLUSIONS: CAA differs from other cSAH in having TFNE as a frequent clinical presentation, a high prevalence of cSS and an increased risk of recurrent subarachnoid bleeding. However, evolution from acute cSAH to focal cSS may not be specific to CAA.
Authors: Markus Beitzke; Thomas Gattringer; Christian Enzinger; Gerit Wagner; Kurt Niederkorn; Franz Fazekas Journal: Stroke Date: 2011-09-15 Impact factor: 7.914
Authors: Markus Beitzke; Christian Enzinger; Gerit Wünsch; Martin Asslaber; Thomas Gattringer; Franz Fazekas Journal: Stroke Date: 2015-05-07 Impact factor: 7.914
Authors: Arnulf H Koeppen; Susan C Michael; Danhong Li; Zewu Chen; Matthew J Cusack; Walter M Gibson; Simone V Petrocine; Jiang Qian Journal: Acta Neuropathol Date: 2008-08-12 Impact factor: 17.088